Literature DB >> 23647765

Montelukast can reduce the severity and extent of atopic dermatitis.

Harriet Holme1, Lucinda C Winckworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23647765     DOI： 10.1111/jpc.12202

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN： 1034-4810            Impact factor:   1.954


× No keyword cloud information.
  4 in total

1.  Comparing efficacy of Montelukast versus doxycycline in treatment of moderate acne.

Authors:  Elham Behrangi; Elahe Arasteh; Tahmine Tavakoli; Golnaz Mehran; Najmolsadat Atefi; Shooka Esmaeeli; Zahra Azizian
Journal:  J Res Med Sci       Date:  2015-04       Impact factor: 1.852

2.  Leukotriene receptor antagonists for eczema.

Authors:  Leila Ferguson; Masaki Futamura; Efstratios Vakirlis; Reiji Kojima; Hatoko Sasaki; Amanda Roberts; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2018-10-21

Review 3.  Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.

Authors:  A J Theron; H C Steel; G R Tintinger; C M Gravett; R Anderson; C Feldman
Journal:  J Immunol Res       Date:  2014-05-25       Impact factor: 4.818

4.  A Double-Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Korean Children.

Authors:  You Hoon Jeon; Taek Ki Min; Hyeon Jong Yang; Bok Yang Pyun
Journal:  Allergy Asthma Immunol Res       Date:  2016-07       Impact factor: 5.764
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.